Delisting riskPopularity #5,339
MEHA · NASDAQ · Packaged Foods

Functional Brands (MEHA)

Manufactures Kirkman supplements and extends them into prenatal and telehealth wellness offerings.

$0.0048
vs last close+0.00 (+2.13%)
Loading prices…

Functional Brands, Inc. Common StockMEHA
Consumer Staples

Manufactures Kirkman and P2i over-the-counter supplements and sells through wholesale, practitioner, international-distributor, e-commerce, and direct channels. Tru2u.health adds outsourced telehealth and medication-based wellness services, while North America supplies most revenue and FDA, FTC, and state healthcare rules shape operations.

Manufactures and distributes over-the-counter nutraceutical supplements through the Kirkman division, including vitamins, probiotics, enzymes, amino acids, fatty acids, immune-support products, and specialty formulas. P2i by Kirkman focuses on prenatal vitamins, while Tru2u.health combines the supplement portfolio with outsourced telehealth support and medication-based wellness programs.

Kirkman products are made at an FDA-registered, cGMP-certified facility in Lake Oswego, with testing of incoming ingredients and finished batches. Sales reach consumers and practitioners through company websites, Amazon, U.S. wholesalers, pharmacies, and distributors serving international markets. North America generates most sales.

Operations depend on supplement demand, retailer and distributor relationships, imported inputs, quality controls, and FDA and FTC regulation. Tru2u.health also depends on CareValidate and compliance with state telehealth and prescribing requirements. Hemp-derived product lines have been discontinued.

Company facts

CEOEric Gripentrog
ListedNov 5, 2025
ExchangeNASDAQ
HeadquartersLake Oswego, OR
CountryUnited States
Employees33
CIK0001837254
ISINUS3609481037

Market cap$198.4K
EPS (ttm)−$0.0921
P/E (ttm)−0.0510
ROE
P/B
P/S0.0296
Dividend yieldDiv yield
Beta1.60vs XLP −0.75

No analyst consensus on record.

EPSReportedEstimate

Mar '26May '26Aug '26
Reported$0.09−$0.36−$0.06
Estimate
Surprise

RevenueReportedEstimate

Mar '26May '26Aug '26
Reported$1.5M$1.6M$1.9M
Estimate
Surprise
Estimate
Reported−$0.06
Estimate
Reported$1.9M
View details

Current ratio48.60%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$1.4M$1.7M$1.6M$1.8M$1.7M$1.5M$1.6M$1.9M
Net income−$282.1K−$283.7K−$126.8K−$226.1K$259.0K$852.3K−$7.0M−$2.6M
Net margin0.0%0.0%0.0%0.0%15.3%57.0%0.0%0.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income−$215.3K−$139.2K−$32.1K−$155.4K−$78.3K−$1.1M−$682.8K−$1.3M
YoY growthLoss widenedLoss narrowedLoss widenedLoss widenedLoss widened

Balance sheet, Jun 30, 2026Cash & short-term investments $352.1K · Total debt $1.7M · Total assets $6.5M · Shareholders' equity −$3.0M

Revenue
$1.9M
Operating income
−$1.3M
Net income
−$2.6M
View details

No dividends on record.

Institutions0.09%39.0K shares
1 holder · as of Jun 30, 2026
Insiders1.68%710.9K shares
1 holder · as of Dec 4, 2025
Other98.23%41.46M shares
remainder

42.21M company shares as of Sep 9, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (64.92M in the company's Sep 22, 2026 report, 42.21M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Eric Jon GripentrogInsiderdirector, officer: Chief Executive Officer
1.68%710,924filed Dec 4, 2025
Guardian Partners Inc.Institution
0.09%38,972as of Jun 30, 2026
Leonite Fund I, LPInstitution
8.80% of class, as filedfiled May 13, 2026

Insider tradesForm 4

Nothing filed in the last 12 months.

View details

Not reported.